A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and Granulocyte Colony Stimulating Factor (G-CSF) as Compared to Placebo and G-CSF for the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Subjects With Multiple Myeloma (MM)
Study sponsor: BioLineRx, Ltd. · BLRX
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2020-12-22Actual
Enrollment · participants180Actual
Source updated2026-01-15Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.